Between 2012 and 2022, the Pharmaceuticals in Dosage Market in Poland experienced fluctuations, starting at 12.514 Billion USD in 2012 and witnessing varying year-on-year changes. Despite a significant dip in 2015 and 2016, the market rebounded with growth in subsequent years, reaching a peak in 2021 at 15.029 Billion USD. The year-on-year percentage variations indicate notable swings, for instance, a sharp decline of 15.54% in 2015 and a later high of 11.76% growth in 2018. Over the last five years, the market has shown an average annual growth rate (CAGR) of 2.75%.
Analyzing future trends, stakeholders should watch for potential impacts of healthcare innovations, regulatory changes, and economic factors on market growth. Additionally, the effects of global health issues and advancements in biotechnology may shape demand and market size in the coming years.
How does Poland rank in Pharmaceuticals in Dosage Market Size Value?
| # | 59 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 110,040,000,000 | 2023 | -0.57% | +2.9% | View data |
| 2 | 2 Japan | 102,270,000,000 | 2023 | +1.29% | +1.27% | View data |
| 3 | 3 Italy | 90,420,000,000 | 2023 | -0.45% | +3.03% | View data |
| 4 | 4 France | 70,241,000,000 | 2023 | -2.11% | -1.64% | View data |
| 5 | 5 United Kingdom | 69,574,000,000 | 2023 | -0.43% | -2.13% | View data |
| 8 | 8 Brazil | 24,977,000,000 | 2023 | -0.94% | +0.08% | View data |
| 9 | 9 Australia | 20,581,000,000 | 2023 | -7.45% | -6.31% | View data |
| 10 | 10 Poland | 12,625,000,000 | 2023 | -2.37% | -1.14% | |
| 11 | 11 Colombia | 9,708,500,000 | 2023 | +3.29% | +3.48% | View data |
| 12 | 12 Israel | 9,602,000,000 | 2023 | +1.67% | +1.92% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
